679 research outputs found

    The Untapped Potential of Commuters: Engaging Faculty and Staff to Foster a Commuter-Inclusive Space and Student Interest at the University of San Diego

    Get PDF
    The commuter student population faces many challenges in getting involved on campus. Taking an asset-based approach, this study aimed to enhance first-year commuter engagement and support their sense of belonging at a private, faith-based university. By modifying McNiff and Whitehead’s model of reflect-plan-act-exhibit, students were invited to engage in several identity, community, and leadership activities throughout the academic year. Results suggest first-year commuters need role modeling or mentorship that is challenging and supportive, the support of creating a ‘third space’ away from home and school, and the development of authentic and genuine connections among peers and staff. It is recommended that practitioners acknowledge and embrace students’ commuter identity and work to increase the visibility and accessibility of commuter-targeted programming. Additionally, staff must build a community among commuter students through dedicated spaces and peer mentoring programs to strengthen and enhance first-year commuter cocurricular engagement

    Desarrollo multidisciplinario en investigaciĂłn y docencia del centro universitario UAEM Valle de MĂ©xico

    Get PDF
    DESARROLLO MULTIDISCIPLINARIO EN INVESTIGACIÓN Y DOCENCIA DEL CENTRO UNIVERSITARIO UAEM VALLE DE MÉXICOLa Universidad AutĂłnoma del Estado de MĂ©xico ha evolucionado a travĂ©s de sus 188 años de historia, dedicada a la educaciĂłn, la investigaciĂłn, la cultura y el deporte, como sus grandes ejes rectores, formadora de hombres y mujeres con un alto sentido humanista y Ă©tico, contribuyendo a lograr nuevas y mejores formas de existencia y convivencia social. Durante el proceso de desconcentraciĂłn de la UAEM, se crearon las Unidades AcadĂ©micas y Centros Universitarios para brindar el servicio de educaciĂłn a mĂĄs jĂłvenes en todo el Estado de MĂ©xico, este Centro Universitario fue uno de los primeros y a sus veinte años de existencia se estĂĄ consolidando como uno de los mejores. Es en los Ășltimos años que se ha venido impulsando la investigaciĂłn al contar con cuerpos acadĂ©micos, en formaciĂłn y en consolidaciĂłn, con infraestructura de primera tanto en equipo como en laboratorios especializados, con profesores de tiempo completo que participan en congresos, seminarios y presentan publicaciones en revistas indexadas. Por ello para celebrar esos veinte años de existencia de esta honorable instituciĂłn, se planeĂł la compilaciĂłn de esta obra que es parte del quehacer multidisciplinario en investigaciĂłn y docencia como parte del Plan de Desarrollo 2013-2017, de esta administraciĂłn. Esta obra reĂșne investigaciones tanto de profesores como de alumnos desde las diferentes ramas del saber en las que se inscriben sus siete licenciaturas, ActuarĂ­a, AdministraciĂłn, ContadurĂ­a, Derecho, EconomĂ­a, Relaciones EconĂłmicas Internacionales e InformĂĄtica Administrativa, tanto presencial como a distancia, asĂ­ como sus tres ingenierĂ­as, Industrial, en ComputaciĂłn y Sistemas y Comunicaciones, asĂ­ como gracias a la vinculaciĂłn y colaboraciĂłn acadĂ©mico – cientĂ­fica que se tiene con otras instituciones de educaciĂłn superior a nivel nacional, como el Instituto TecnolĂłgico de Orizaba, la Universidad AutĂłnoma de San Luis PotosĂ­, la Universidad Nacional AutĂłnoma de MĂ©xico, la Universidad AutĂłnoma Metropolitana, Universidad PolitĂ©cnica de Victoria, el Instituto PolitĂ©cnico Nacional entre otras. En el capĂ­tulo 1 se abordan seis temĂĄticas diferentes de vanguardia en el ĂĄrea de las IngenierĂ­as, en los capĂ­tulos 2 y 3 se incluyen temas de interĂ©s y gran relevancia en materia de ciencias sociales, polĂ­tica y economĂ­a. Se hace extensivo un reconocimiento para todos los que participaron tanto en la revisiĂłn de los trabajos, como en la compilaciĂłn del producto final de este Libro intitulado “Desarrollo Multidisciplinario en InvestigaciĂłn y Docencia del Centro Universitario UAEM Valle de MĂ©xico”

    Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

    Get PDF
    BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

    RecuperaciĂłn monumental ambiental de la Alameda Central de la Ciudad de MĂ©xico

    No full text
    752 pĂĄginas. EspecializaciĂłn en Diseño.El presente trabajo se centra en el estudio, anĂĄlisis y rescate de la Alameda Central de la Ciudad de MĂ©xico, la cual se sitĂșa hoy en el corazĂłn de la gran ciudad, siendo Ă©sta el paseo mĂĄs antiguo de AmĂ©rica y lugar que ha visto acontecer los cambios polĂ­ticos, sociales y culturales de una naciĂłn, que es hoy MĂ©xico. El estudio es una recopilaciĂłn cronolĂłgica de los sucesos que dieron origen al primer parque pĂșblico de MĂ©xico, asĂ­ como su desarrollo y los cambios morfolĂłgicos que ha presentado a lo largo de los años, lo que le otorga un carĂĄcter relevante y lo define como el paseo mĂĄs importante del paĂ­s

    Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

    Get PDF
    BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

    The Forward Physics Facility at the High-Luminosity LHC

    Get PDF

    Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial

    Get PDF
    • 

    corecore